Know Cancer

forgot password

Adolescent and Young Adult Cancer Survivors: Identity Development

15 Years
25 Years
Open (Enrolling)

Thank you

Trial Information

Adolescent and Young Adult Cancer Survivors: Identity Development

Inclusion Criteria:

- Current age greater than and including 15 and up to and including 25 years of age at
time of consent

- Diagnosis of a first cancer > or = to 14 and up to and including 21 years of age

- At least 6 months post-treatment according to participant's self-report.

- Able to provide informed consent (or parent or legal guardian consent and participant
assent for those participants under 18 years of age)

- Able to speak English. This inclusion criterion is included because study assessments
were designed and validated in English and many of them are not currently available
in other languages. Translation of questionnaires into other languages would require
reestablishing the reliability and validity of these measures. Therefore,
participants must be able to communicate in English to complete the assessments.

Exclusion Criteria:

- Will exclude survivors with severe cognitive impairment that precludes them from
being able to give information consent and/or complete the questionnaires.

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Conduct a comprehensive qualitative assessment through individual interviews and focus groups of identity development, peer and family relationships, and psychosocial concerns among survivors diagnosed during adolescence.

Outcome Time Frame:

3 years

Safety Issue:


Principal Investigator

Jennifer Ford, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

January 2009

Completion Date:

January 2014

Related Keywords:

  • Cancer
  • Childhood Survivor
  • survivors
  • Young Adult Cancer Survivors
  • Childhood cancers
  • 09-001



Memorial Sloan-Kettering Cancer Center New York, New York  10021